Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Biofinderon May 23, 2018 7:23pm

192 Views

Post# 28072378

RE:RE:RE:RE:Did You Notice CC Abbott’s “Disclosures”?

37minus4 wrote: Bio, I think the Still a Buy article was directly after the delay but the real question - that will go unanswered - is:

CC, who told you or how did you get the heads up that the FDA was going to f u c k Prometic?

RBC clearly knew as well amongst others.

Keep the hits coming!

;-) 33

I think it may relate back to my May 22nd post, “How was Prometic Played you ask?” The truth is somewhere, and I imagine it’s somewhere centered around money and influence, or somewhere in the middle... big fish eat little fish.

Bullboard Posts

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle